Major deals

Takeda sells its Japanese division Japan Consumer Health Care to Blackstone for approximately JPY242 billion. TCHC's revenue for fiscal 2019 was JPY60 billion. Its OTC portfolio includes Alinamin, Japan's best-selling drug. The deal is expected to be closed by March 31, 2021.